Terrance P. Coyne - 08 Nov 2022 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role: EVP & CFO
Signature: /s/ Sean Weisberg, as Attorney-in-Fact for Terrance P. Coyne
Issuer symbol: RPRX
Transactions as of: 08 Nov 2022
Net transactions value: -$1,065,013
Form type: 4
Filing time: 10 Nov 2022, 16:04:19 UTC
Previous filing: 04 Nov 2022
Next filing: 14 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPRX	Class A Ordinary Shares	Sale	$1,065,013	-24,500	-2.5%	$43.47	940,000	08 Nov 2022	By TPC RP 2021, LLC	F1
holding	RPRX	Class A Ordinary Shares						1,500	08 Nov 2022	Direct
holding	RPRX	Class A Ordinary Shares						1,450	08 Nov 2022	By Spouse
holding	RPRX	Class A Ordinary Shares						23,270	08 Nov 2022	By IRA
holding	RPRX	Class A Ordinary Shares						24,170	08 Nov 2022	By Spouse's IRA

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.85 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.85 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

All reported transactions were effected pursuant to a 10b5-1 plan adopted by the reporting person.